Nymox Pharmaceutical NYMXF
OTC NYMXF
$0.04 -0.02 (-33.33%)
As of: Oct 23, 2026 · 9:30 AM EDT

Nymox Pharmaceutical (NYMXF) Total Debt (2015 - 2021)

Updated

Nymox Pharmaceutical's Total Debt was $445,000 in Q3 2021, up 45.0% from the prior quarter.

Analysis

Nymox Pharmaceutical (NYMXF) Total Debt (2015 - 2021) Analysis & Trends

At the end of FY2020, Total Debt at Nymox Pharmaceutical came in at $368,000.

  • Total Debt shows a five-year compound annual growth rate of -14.7% (FY2015 to FY2020).
  • In earlier years, Total Debt was $3,000 in FY2019 and $931,000 in FY2016 (+14.4%).
  • The Q3 2021 figure marks the highest quarterly Total Debt since Q4 2016.
  • Per Business Quant data, NYMXF's Total Debt in the three quarters before Q3 2021 was $307,000 (Q2 2021), $338,000 (Q1 2021) and $368,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 44.65 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 70.82 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 32.35 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 26.25 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 63.19 Bn
10 Nymox Pharmaceutical 3.84 Mn 3.65 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 445,000.00
Jun 30, 2021 307,000.00
Mar 31, 2021 338,000.00
Dec 31, 2020 368,000.00
Dec 31, 2019 3,000.00
Dec 31, 2016 931,000.00
Dec 31, 2015 814,000.00
API Access

Nymox Pharmaceutical Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=NYMXF&period=max&api_key=YOUR_API_KEY